Robert J Desnick

This inventor holds 28 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Gene Therapy. Top assignees: Icahn School of Medicine at Mount Sinai, Alnylam Pharmaceuticals, Inc., Genzyme Corporation. Active years: 1994-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert J Desnick. Retrieved from https://idiyas.com/inventor/robert-j-desnick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 13)

% Patents Active = 96.4

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 3.2

ph-index = 13

Forward Citations = 505(Granted Patents)

Company Filing History:

26 out of 538

Icahn School of Medicine at Mount Sinai

patents

6 out of 466

Alnylam Pharmaceuticals, Inc.

The Brigham and Women's Hospital, Inc.

patents

5. 1 out of 4

The Mount Sinai Medical Center

patents

6. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1994-2022

Loading Chart...

Areas of Expertise:

Gene Therapy

Spinal Muscular Atrophy

Niemann-Pick Disease

Enzyme Replacement Therapy

Acid Sphingomyelinase

Lysosomal Storage Disorders

Polymorphism Detection

Biologically Active Proteins

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11279977 - Materials and methods for identifying spinal muscular atrophy carriers (2022-03-22),

2. 11028392 - Compositions and methods for inhibiting expression of the ALAS1 gene (2021-06-08),

3. 10400239 - Compositions and methods for inhibiting expression of the ALAS1 gene (2019-09-03),

4. 10188705 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency (2019-01-29),

5. 10125364 - Compositions and methods for inhibiting expression of the ALAS1 gene (2018-11-13),

6. 10119143 - Compositions and methods for inhibiting expression of the ALAS1 gene (2018-11-06),

7. 9994898 - Materials and methods for identifying spinal muscular atrophy carriers (2018-06-12),

8. 9655954 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency (2017-05-23),

9. 9631193 - Compositions and methods for inhibiting expression of the ALAS1 gene (2017-04-25),

10. 9133461 - Compositions and methods for inhibiting expression of the ALAS1 gene (2015-09-15),

11. 9114139 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency (2015-08-25),

12. 8709408 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency (2014-04-29),

13. 8658162 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency (2014-02-25),

14. 8349319 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency (2013-01-08),

15. 7750050 - Chaperone-based therapy for Niemann-Pick disease (2010-07-06),

Title: The Innovative Journey of Robert J. Desnick

Introduction: Robert J. Desnick is a renowned inventor based in New York, NY (US) known for his groundbreaking contributions to the field of inventions and patents.

Latest Patents: Robert J. Desnick holds several patents in various industries, showcasing his diverse range of innovative ideas and solutions.

Career Highlights: Throughout his illustrious career, Robert J. Desnick has been instrumental in developing cutting-edge technologies that have revolutionized the way we approach different challenges. His work has significantly impacted the fields of science, technology, and healthcare.

Collaborations: Robert J. Desnick has collaborated with leading companies, research institutions, and universities to further his inventions and bring them to life. His partnerships have been crucial in turning his visionary ideas into tangible products and services.

Conclusion: In conclusion, Robert J. Desnick stands as a beacon of innovation in the world of inventions and patents, with a legacy that continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.